Next Article in Journal
The Blood Circulating Rare Cell Population. What is it and What is it Good For?
Next Article in Special Issue
Key Components of Human Myofibre Denervation and Neuromuscular Junction Stability are Modulated by Age and Exercise
Previous Article in Journal
Phenol-Soluble Modulin-Mediated Aggregation of Community-Associated Methicillin-Resistant Staphylococcus Aureus in Human Cerebrospinal Fluid
Previous Article in Special Issue
The Transcription Factor Nfix Requires RhoA-ROCK1 Dependent Phagocytosis to Mediate Macrophage Skewing during Skeletal Muscle Regeneration
Open AccessArticle

The Switch from NF-YAl to NF-YAs Isoform Impairs Myotubes Formation

Dipartimento di Bioscienze, Università degli Studi di Milano, Via Celoria 26, 20133 Milano, Italy
*
Author to whom correspondence should be addressed.
Cells 2020, 9(3), 789; https://doi.org/10.3390/cells9030789
Received: 14 February 2020 / Revised: 19 March 2020 / Accepted: 21 March 2020 / Published: 24 March 2020
NF-YA, the regulatory subunit of the trimeric transcription factor (TF) NF-Y, is regulated by alternative splicing (AS) generating two major isoforms, “long” (NF-YAl) and “short” (NF-YAs). Muscle cells express NF-YAl. We ablated exon 3 in mouse C2C12 cells by a four-guide CRISPR/Cas9n strategy, obtaining clones expressing exclusively NF-YAs (C2-YAl-KO). C2-YAl-KO cells grow normally, but are unable to differentiate. Myogenin and—to a lesser extent, MyoD— levels are substantially lower in C2-YAl-KO, before and after differentiation. Expression of the fusogenic Myomaker and Myomixer genes, crucial for the early phases of the process, is not induced. Myomaker and Myomixer promoters are bound by MyoD and Myogenin, and Myogenin overexpression induces their expression in C2-YAl-KO. NF-Y inactivation reduces MyoD and Myogenin, but not directly: the Myogenin promoter is CCAAT-less, and the canonical CCAAT of the MyoD promoter is not bound by NF-Y in vivo. We propose that NF-YAl, but not NF-YAs, maintains muscle commitment by indirectly regulating Myogenin and MyoD expression in C2C12 cells. These experiments are the first genetic evidence that the two NF-YA isoforms have functionally distinct roles. View Full-Text
Keywords: splicing isoforms; CRISPR-Cas9; exon deletion; NF-Y; muscle differentiation; C2C12 cells splicing isoforms; CRISPR-Cas9; exon deletion; NF-Y; muscle differentiation; C2C12 cells
Show Figures

Figure 1

MDPI and ACS Style

Libetti, D.; Bernardini, A.; Sertic, S.; Messina, G.; Dolfini, D.; Mantovani, R. The Switch from NF-YAl to NF-YAs Isoform Impairs Myotubes Formation. Cells 2020, 9, 789.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop